Effects of nutritional therapy on gastrointestinal microbial digestion and barrier defense markers in elderly patients with diabetes.
Barrier defense
Diabetes mellitus
Elderly patients
Gastrointestinal nutrition therapy
Intestinal microbes
Journal
Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
30
05
2023
accepted:
25
07
2023
medline:
8
11
2023
pubmed:
12
10
2023
entrez:
11
10
2023
Statut:
ppublish
Résumé
We sought to investigate the effects of gastrointestinal nutrition therapy on gastrointestinal microbial digestion and barrier defense markers in elderly patients with diabetes. A total of 120 elderly patients with type 2 diabetes were enrolled at our hospital between January 2020 and December 2022. The participants in this study were randomly allocated into either the nutritional group (n = 60) who underwent gastrointestinal nutrition therapy or the control group (n = 60) who underwent conventional T2DM diet management for a period of 12 weeks. Clinical data, as well as small intestinal permeability measured by the lactulose-mannitol urine test, plasma circulating IL-6 and zonulin levels measured by ELISA, and expressions of ZO-1 and Claudin-3 in blood analyzed through Western blotting were collected. The nutrition group demonstrated a higher proportion of patients achieving HbA1c < 7% compared to the control group (P < 0.05). Moreover, the nutrition group exhibited a greater reduction in fasting and postprandial blood glucose levels compared to the control group (P < 0.05). The concentrations of formate-tetrahydrofolate ligase and acetic CoA transferase were significantly increased in the nutrition group compared to the control group (P < 0.05). Fecal analysis revealed higher levels of acetic acid and butyric acid in the nutrition group compared to the control group (P < 0.05). The ratio of lactulose to mannitol was higher in the nutrition group compared to the control group (P < 0.05). Furthermore, the nutrition group showed lower levels of IL-6 and zonulin compared to the control group (P < 0.05). Personalized gastrointestinal nutrition therapy was found to enhance the production of short-chain fatty acids and preserve intestinal permeability, leading to improved gastrointestinal microbial digestion and barrier defense in elderly patients with diabetes.
Identifiants
pubmed: 37821689
doi: 10.1007/s40520-023-02518-4
pii: 10.1007/s40520-023-02518-4
doi:
Substances chimiques
Lactulose
4618-18-2
Interleukin-6
0
Mannitol
3OWL53L36A
Types de publication
Randomized Controlled Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2667-2674Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Abu Dayyeh BK, Maselli DB et al (2021) Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial. Lancet 398:1965–1973
doi: 10.1016/S0140-6736(21)02394-1
pubmed: 34793746
Amin A, Frampton J (2021) Differential effects of L- and D-phenylalanine on pancreatic and gastrointestinal hormone release in humans: a randomized crossover study. Diabetes Obes Metab 23:147–157
doi: 10.1111/dom.14204
pubmed: 32991046
Bargetzi L, Brack C, Herrmann J et al (2021) Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trial. Ann Oncol 32:1025–1033
doi: 10.1016/j.annonc.2021.05.793
pubmed: 34022376
Biruete A, Cross TL, Allen JM et al (2021) Effect of dietary inulin supplementation on the gut microbiota composition and derived metabolites of individuals undergoing hemodialysis: a pilot study. J Renal Nutr 31:512–522
doi: 10.1053/j.jrn.2020.10.003
Casajoana A, Guerrero-Pérez F, García Ruiz de Gordejuela A et al (2021) Role of Gastrointestinal hormones as a predictive factor for long-term diabetes remission: randomized trial comparing metabolic gastric bypass, sleeve gastrectomy, and greater curvature plication. Obesity Surg 31:1733–1744
Chen X, Xu Y, Zhang J et al (2021) Exenatide twice daily plus glargine versus aspart 70/30 twice daily in patients with type 2 diabetes with inadequate glycemic control on premixed human insulin and metformin. Endocr Pract 27:790–797
doi: 10.1016/j.eprac.2021.03.015
pubmed: 33831552
Delannoy-Bruno O, Desai C (2021) Evaluating microbiome-directed fibre snacks in gnotobiotic mice and humans. Nature 595:91–95
doi: 10.1038/s41586-021-03671-4
pubmed: 34163075
pmcid: 8324079
Dicks L, Jakobs L, Sari M et al (2022) Fortifying a meal with oyster mushroom powder beneficially affects postprandial glucagon-like peptide-1, non-esterified free fatty acids and hunger sensation in adults with impaired glucose tolerance: a double-blind randomized controlled crossover trial. Eur J Nutr 61:687–701
doi: 10.1007/s00394-021-02674-1
pubmed: 34505919
Ewers B, Vilsbøll T, Andersen HU et al (2019) The dietary education trial in carbohydrate counting (DIET-CARB Study): study protocol for a randomised, parallel, open-label, intervention study comparing different approaches to dietary self-management in patients with type 1 diabetes. BMJ Open 9:e029859
doi: 10.1136/bmjopen-2019-029859
pubmed: 31481560
pmcid: 6731880
Farsijani S, Cauley JA, Peddada SD et al (2023) Relation between dietary protein intake and gut microbiome composition in community-dwelling older men: findings from the osteoporotic fractures in men study (MrOS). J Nutr 152:2877-2887
Fleseriu M, Dreval A, Bondar I et al (2022) Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial. Lancet Diabetes Endocrinol 10:102–111
doi: 10.1016/S2213-8587(21)00296-5
pubmed: 34953531
Ai D, Ding N, Wu H (2023) The impact of sarcopenia on nutritional status in elderly patients with gastrointestinal tumors. Sci Rep 13:10308
doi: 10.1038/s41598-023-37470-w
pubmed: 37365298
pmcid: 10293185
Frias JP, Lee ML, Carter MM et al (2023) A microbiome-targeting fibre-enriched nutritional formula is well tolerated and improves quality of life and haemoglobin A1c in type 2 diabetes: a double-blind, randomized, placebo-controlled trial. Diabetes Obes Metab 25:1203–1212
doi: 10.1111/dom.14967
pubmed: 36594522
Gao J, Guo X, Wei W et al (2021) The association of fried meat consumption with the gut microbiota and fecal metabolites and its impact on glucose homoeostasis. Intestinal Endotoxin Levels Syst Inflammation 44:1970–1979
Garvey WT, Batterham RL (2022) Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med 28:2083–2091
doi: 10.1038/s41591-022-02026-4
pubmed: 36216945
pmcid: 9556320
Homayouni A, Bagheri N, Mohammad-Alizadeh-Charandabi S et al (2020) Prevention of gestational diabetes mellitus (GDM) and probiotics: mechanism of action: a review. Curr Diabetes Rev 16:538–545
pubmed: 31544699
Hosomi R, Nishimoto A, Kobayashi T (2020) Dietary Alaska pollock protein alters insulin sensitivity and gut microbiota composition in rats. J Food Sci 85:3628–3637
doi: 10.1111/1750-3841.15413
pubmed: 32885439
Kahleova H, Tintera J, Thieme L et al (2021) A plant-based meal affects thalamus perfusion differently than an energy- and macronutrient-matched conventional meal in men with type 2 diabetes, overweight/obese, and healthy men: a three-group randomized crossover study. Clin Nutr 40:1822–1833
doi: 10.1016/j.clnu.2020.10.005
Katada C, Fukazawa S, Sugawara M et al (2021) Randomized study of prevention of gastrointestinal toxicities by nutritional support using an amino acid-rich elemental diet during chemotherapy in patients with esophageal cancer (KDOG 1101). Esophagus 18:296–305
doi: 10.1007/s10388-020-00787-w
pubmed: 33009977
Wu H, Li A, Zheng Q et al (2023) LncRNA LZTS1-AS1 induces proliferation, metastasis and inhibits autophagy of pancreatic cancer cells through the miR-532 /TWIST1 signaling pathway. Cancer Cell Int 23:130
doi: 10.1186/s12935-023-02979-7
pubmed: 37403096
pmcid: 10320869
Leyrolle Q, Cserjesi R, M DGHM, Zamariola G, et al (2021) Prebiotic effect on mood in obese patients is determined by the initial gut microbiota composition: a randomized, controlled trial. Brain Behavior Immunity 94:289–298.
Lin S, Li C, Shen J et al (2022) Loop versus Roux-en-Y duodenojejunal bypass with sleeve gastrectomy for type 2 diabetes: short-term outcomes of a single-center randomized controlled trial. Surg Obe Related Dis 18:1277–1285
doi: 10.1016/j.soard.2022.07.003
Meessen ECE, Bakker GJ, Nieuwdorp M et al (2021) Parenteral nutrition impairs plasma bile acid and gut hormone responses to mixed meal testing in lean healthy men. Clin Nutr 40:1013–1021
doi: 10.1016/j.clnu.2020.06.032
Mohamed Elfadil O, Linch FB et al (2022) Safety and effectiveness of radiologic and endoscopic percutaneous gastrostomy placement: a randomized study. J Parenter Enteral Nutr 46:1808–1817
Mokkala K, Paulin N (2021) Metagenomics analysis of gut microbiota in response to diet intervention and gestational diabetes in overweight and obese women: a randomised, double-blind, placebo-controlled clinical trial. Gut 70:309–318
pubmed: 32839200
Newsome PN, Buchholtz K, Cusi K et al (2021) A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. N Engl J Med 384:1113–1124
doi: 10.1056/NEJMoa2028395
pubmed: 33185364
Neyrinck AM, Rodriguez J (2021) Prebiotic dietary fibre intervention improves fecal markers related to inflammation in obese patients: results from the Food4Gut randomized placebo-controlled trial. Eur J Nutr 60:3159–3170
doi: 10.1007/s00394-021-02484-5
pubmed: 33544206
pmcid: 8354918